The benefits of refractive index (RI) in development and production of Active Pharmaceutical Ingredients (APIs) Industrial Manufacturing and Processes Industrial Measurements Life Science Liquid Measurements
In this 1-hour webinar with Vaisala, Liquid Measurements’ Pharma Industry Expert Juha Paldanius and Application Engineer Daniela Kokkonen, we present real customer cases on how in-line process refractometer can be used as a PAT tool for standardizing and scaling-up APIs production. The participants will learn how RI measurement technology is commonly applied in pharmaceutical reaction, separation and purification, solvent swap, and crystallization operations – first in laboratory and pilot scales and finally in full-scale commercialized production.API manufacturers are more increasingly moving towards continuous manufacturing and advancing the PAT framework, which guides the pharmaceutical development, manufacturing and quality assurance. PAT also promotes the adoption of real-time measurements throughout the entire process. The ability to understand and continuously measure and control parameters, such as Refractive Index (RI) or liquid concentration can contribute significantly to more efficient development and manufacturing of the APIs.As an added benefit, the scalability of the K-PATENTS® RI technology helps the drug manufacturers to streamline development and improve product reliability throughout the complete process analysis. TopicsReview in-line process refractometer and RI measurement technology.Learn how APIs production process, i.e. pharmaceutical reaction, separation and purification, solvent swap, and crystallization operations, can be developed and scaled-up using RI measurement as a PAT tool.Key factors to consider when selecting in-line pharma instrumentation.Explore all applications for pharmaceutical drug manufacturing and biotechnology processesThis webinar is of interest toPharmaceutical companies that make Active Pharmaceutical Ingredients APIs (specialty chemicals that have a disease-curing value). Pharma companies that plan Process Analytical Technology PAT implementation project and/or plan to increase their production capacity.Target audiencePrincipal scientistsR&D managersPAT development engineers and managers Process engineers This webinar includes a Question & Answer period to elaborate on the topics. By submitting this form you acknowledge Vaisala’s Privacy PolicyWebinar presentation (PDF) Email Address*Country*--Please Select--United StatesUnited KingdomCanadaChinaIndiaJapanAustraliaBrazilFranceGermanyFinland--------------AfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBrit/Indian Ocean Terr.Brunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, The Dem. Republic OfCook IslandsCosta RicaCôte D'IvoireCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern Terr.GabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuineaGuinea-BissauGuyanaHaitiHeard/McDonald Isls.HondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKiribatiKorea (North)Korea (South)KuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarN. Mariana Isls.NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern IrelandNorwayOmanPakistanPalauPalestinian Territory, OccupiedPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarReunionRomaniaRussian FederationRwandaSaint Kitts and NevisSaint LuciaSamoaSan MarinoSao Tome/PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovak RepublicSloveniaSolomon IslandsSomaliaSouth AfricaSpainSri LankaSt. HelenaSt. Pierre and MiquelonSt. Vincent and GrenadinesSudanSurinameSvalbard/Jan Mayen Isls.SwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks/Caicos Isls.TuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUS Minor Outlying Is.UruguayUzbekistanVanuatuVatican CityVenezuelaViet NamVirgin Islands (British)Virgin Islands (U.S.)Wallis/Futuna Isls.Western SaharaYemenZambiaZimbabweState or Province*--Please Select--Other - not US or CAAlaskaAlabamaArkansasArizonaCaliforniaColoradoConnecticutD.C.DelawareFloridaMicronesiaGeorgiaHawaiiIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMaineMichiganMinnesotaMissouriMarianasMississippiMontanaNorth CarolinaNorth DakotaNebraskaNew HampshireNew JerseyNew MexicoNevadaNew YorkOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVirginiaVermontWashingtonWisconsinWest VirginiaWyomingAlbertaManitobaBritish ColumbiaNew BrunswickNewfoundland and LabradorNova ScotiaNorthwest TerritoriesNunavutOntarioPrince Edward IslandQuebecSaskatchewanYukon TerritoryFirst Name*Last Name*Company*TitleBusiness Phone*I authorize Vaisala to send me information about relevant products and services. See our Privacy Policy for more details. You can modify your preference settings or unsubscribe at any time here
Speakers Juha Paldanius Vaisala, K-Patents Liquid Measurements Industry Expert, Pharma Email [email protected] Daniela de Kokkonen Daniela de Kokkonen Research Scientist Email [email protected]
Juha Paldanius Vaisala, K-Patents Liquid Measurements Industry Expert, Pharma Email [email protected]